Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regen BioPharma (RGBPP) Debt Ratio (2016 - 2024)

Historic Debt Ratio for Regen BioPharma (RGBPP) over the last 9 years, with Q2 2024 value amounting to 4.7.

  • Regen BioPharma's Debt Ratio rose 6764.57% to 4.7 in Q2 2024 from the same period last year, while for Jun 2024 it was 4.7, marking a year-over-year increase of 6764.57%. This contributed to the annual value of 2.69 for FY2023, which is 10328.21% up from last year.
  • Regen BioPharma's Debt Ratio amounted to 4.7 in Q2 2024, which was up 6764.57% from 6.7 recorded in Q1 2024.
  • In the past 5 years, Regen BioPharma's Debt Ratio ranged from a high of 105.85 in Q1 2022 and a low of 0.56 during Q2 2021
  • Over the past 5 years, Regen BioPharma's median Debt Ratio value was 2.24 (recorded in 2020), while the average stood at 8.69.
  • Its Debt Ratio has fluctuated over the past 5 years, first surged by 528366.18% in 2022, then plummeted by 9814.14% in 2023.
  • Regen BioPharma's Debt Ratio (Quarter) stood at 2.32 in 2020, then plummeted by 52.23% to 1.11 in 2021, then skyrocketed by 78.46% to 1.98 in 2022, then skyrocketed by 201.81% to 5.98 in 2023, then dropped by 21.36% to 4.7 in 2024.
  • Its last three reported values are 4.7 in Q2 2024, 6.7 for Q1 2024, and 5.98 during Q4 2023.